To determine the relationship between the distribution of
InsP3 receptor isoforms and
Ca
i 2+ signaling patterns, we
tried to identify an agonist that increases
Ca
i 2+ via InsP3 in NPE cells.
Acetylcholine increases Ca
i 2+ in
NPE cells,
22 33 34 35 so we examined whether this increase
is mediated by InsP3. Acetylcholine (10 μM) increased fluo-3
fluorescence by 175% ± 25% (mean ± SEM) in these cells but by
only 10% ± 1% when cells were stimulated in the presence of 10 μM
atropine (
n = 10 experiments;
P <
0.0001 by paired
t-test). In separate studies, ACh increased
fluo-3 fluorescence by 126% ± 18% in the presence of 1.26 mM
extracellular Ca
2+ and by 110% ± 14% in
Ca
2+-free medium (
n = 10
experiments;
P > 0.05). These findings demonstrate
that ACh increases Ca
i 2+ in NPE
cells via stimulation of muscarinic receptors, leading to release of
Ca
2+ from intracellular stores. It has previously
been shown that carbachol stimulates production of inositol
polyphosphates, including InsP3, in NPE cells,
36 so we
examined the time course of InsP3 production. Acetylcholine (10 μM)
induced a net increase of 0.3, 6.8, and 9.9 pmol InsP3/mg protein after
2, 5, and 10 seconds of stimulation, respectively. These values
correspond to increases of 1%, 20%, and 32% relative to InsP3
content of unstimulated controls. To demonstrate a causal link between
ACh-induced InsP3 production and
Ca
i 2+ signaling in NPE cells, we
examined the effects of the phospholipase C inhibitor
U73122.
37 Ciliary epithelial bilayers were sequentially
stimulated, first with ACh (10 μM), then with ACh + U73122 (10 μM),
and then with ACh again. Fluo-3 fluorescence was monitored in groups of
at least 10 adjacent NPE cells, and we found that the ACh-induced
increase in Ca
i 2+ was reversibly
inhibited by U73122
(Fig. 2) . To investigate whether this Ca
2+ release is
mediated by activation of the InsP3 receptor, cells were microinjected
with either heparin (1 mg/ml), which is a high-affinity competitive
antagonist for the InsP3 receptor,
38 or
de-
N-sulfated heparin (1 mg/ml), which neither inhibits
InsP3 binding to its receptor nor blocks InsP3-induced
Ca
2+ release from microsomes.
39 As
an extra control, only cells that responded to ACh were subsequently
injected with heparin or its de-
N-sulfated analogue, then
each of those cells were restimulated with ACh after microinjection.
Ten of 11 cells did not respond to ACh after injection with heparin
(
Figs. 3 A, 3B, 3C); fluorescence increased by 125% ± 30% in these cells when
stimulated before heparin injection, but by only 9% ± 1% after
injection (
P < 0.005 by paired
t-test). In
contrast, 6 of 7 cells responded to ACh after injection with
de-
N-sulfated heparin
(Fig. 3D) ; fluorescence increased by
108% ± 31% in these cells when stimulated before injection, and by
102% ± 31% after injection (
P = 0.31). Taken
together, these studies demonstrate that ACh increases
Ca
i 2+ in NPE cells by
stimulation of muscarinic receptors, which then leads to phospholipase
C–mediated mobilization of intracellular Ca
2+ stores by activation of InsP3 receptors.